Archive for category: News

Ampersand Biosciences Receives SBIR Grant 2024

October 29, 2024/in News

Ampersand Biosciences was cited in the article titled, “Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis” for measuring cytokine and chemokine content in plasma samples that could measure drug exposure in mice of linagliptin, a DDP-4 (dipeptidyl peptidase-4) ihibitor.

Species: Mouse

Focus: Sepsis induced pro-inflammatory cytokine and chemokine production.

Ampersand Biosciences Partners with Bioz

July 24, 2024/in News

Ampersand Biosciences was cited in the article titled, “Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis” for measuring cytokine and chemokine content in plasma samples that could measure drug exposure in mice of linagliptin, a DDP-4 (dipeptidyl peptidase-4) ihibitor.

Species: Mouse

Focus: Sepsis induced pro-inflammatory cytokine and chemokine production.

Ampersand Biosciences participates in Touch a Truck Funraiser 2023

September 17, 2023/in News

Ampersand Biosciences was cited in the article titled, “Dipeptidyl peptidase-4 inhibitor linagliptin reduces inflammatory response, ameliorates tissue edema formation, and improves survival in severe sepsis” for measuring cytokine and chemokine content in plasma samples that could measure drug exposure in mice of linagliptin, a DDP-4 (dipeptidyl peptidase-4) ihibitor.

Species: Mouse

Focus: Sepsis induced pro-inflammatory cytokine and chemokine production.